Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
17.53
+0.75 (4.47%)
At close: Jun 18, 2026, 4:00 PM EDT
17.70
+0.17 (0.97%)
After-hours: Jun 18, 2026, 7:50 PM EDT

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,8062,4978877111,0933,968
Market Cap Growth
85.05%181.67%24.72%-34.98%-72.44%-51.25%
Enterprise Value
2,7772,356753.51463.15703.063,726
Last Close Price
17.5316.246.004.907.6428.06
PS Ratio
9.509.024.954.185.9025.71
PB Ratio
12.9411.414.372.312.366.57
P/TBV Ratio
28.4625.1210.993.843.228.27
EV/Sales Ratio
9.408.514.212.723.7924.14
Debt / Equity Ratio
0.310.310.390.290.210.18
Net Debt / Equity Ratio
-0.65-0.68-0.66-0.80-0.84-0.40
Net Debt / EBITDA Ratio
4.723.760.931.212.181.24
Net Debt / FCF Ratio
4.763.021.341.481.950.95
Asset Turnover
0.580.530.300.220.210.15
Inventory Turnover
6.957.826.305.233.442.96
Quick Ratio
3.063.082.694.374.903.26
Current Ratio
3.353.342.894.665.123.54
Return on Equity (ROE)
-22.10%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-9.17%-10.86%-27.08%-29.92%-22.49%-20.49%
Return on Invested Capital (ROIC)
-17.02%-19.24%-51.49%-67.09%-41.11%-38.97%
Return on Capital Employed (ROCE)
-11.10%-13.22%-32.05%-34.40%-25.72%-22.95%
Buyback Yield / Dilution
-3.62%-3.14%-1.88%-1.31%-1.54%-6.96%
Total Shareholder Return
-3.62%-3.14%-1.88%-1.31%-1.54%-6.96%
SEC Filings: 10-K · 10-Q